Sign up Australia
Proactive Investors - Run By Investors For Investors

SDI Limited gains nod for dental products in Brazil

SDI Limited gains nod for dental products in Brazil

SDI Limited (ASX:SDI) has been granted approval by Brazilian regulator ANVISA to manufacture its dental restoration products in the country.

This will allow the company to develop its Latin American markets by becoming more competitive with local manufacturers and importers.

SDI will initially package bulk product made in Australia, allowing it to benefit from reduced labour costs and savings on freight and duty costs. This will begin in early 2016.

This will also reduce its inventory levels as it can implement a 'just in time' inventory management system.

The company reported a 5.1% increase in sales revenue to $68.7 million while EBITDA is up 15.2% to $12.3 million.

It had $5 million in cash and cash equivalents as at 30th June 2015.

 

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong.

View full SDI profile View Profile

SDI Ltd Timeline

Related Articles

Flow chart of the Hazer Process
March 21 2018
The Hazer Process could disrupt the $100 billion hydrogen production market.
1510592057_gas-pipeline.jpg
November 14 2017
In the quarter, the power and electromechanical segment contributed revenues of $16.7 million,
UUV-Aquabotix_Hybrid-and-Endura-pic-757.jpg
June 19 2017
Brendan Martin talked underwater drone technology and commercialisation.

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use